3-Bromo-6-(trifluoromethyl)-1H-pyrrolo[3,2-c]pyridine, 98+%, 1g

1-(Azetidin-3-yl)-3,3-difluoropyrrolidine dihydrochloride, 95.0%, 250mg

1-Boc-4-(2,4-Difluorobenzoyl)piperidine, 97.0%, 1g

1-(Tetrahydro-2H-pyran-2-yl)-1H-imidazole-5-boronic acid pinacol ester, 95.0%, 250mg

3-Bromo-2-cyanopyridine, 98.0%, 500g

4-(Morpholine-4-sulfonyl)-aniline, 95.0%, 5g

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 500mg

(S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-OL, 95.0%, 1g

1-(tert-Butoxycarbonyl)-4-[3-(trifluoromethyl)benzyl]piperidine-4-carboxylic aci, 1g

2-(4-FLUOROPHENYL)ACETOHYDRAZIDE HCL, 95.0%, 50g

Microliter syringe MICROLITER® series 700 Point type 3, 50 µl, 705 NR, 1 piece

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-biotinyl-L-lysine>95.0%(HPLC)(T)1g

1-(3,5-Difluoro-2-methoxyphenyl)ethanone, 97.0%, 1g